Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Divorce Abbott style

Executive Summary

Ex-Abbott Chairman Robert Schoellhorn is suing his former employer in Cook County Circuit Court to reverse his dismissal. The firm has accelerated the schedule for the change-in-command to Duane Burnham. Named president in early December, Burnham was elevated to chairman on March 9. He was supposed to take over that job from Schoellhorn in August. Schoellhorn is also being removed from the board. Acrimony has surrounded Schoellhorn's executive reign during the last decade. His departure amidst a corporate feud may be fitting given the executive in-fighting during his tenure, but it is not a graceful ending to a period of great growth for the company during his 16-year career.

Ex-Abbott Chairman Robert Schoellhorn is suing his former employer in Cook County Circuit Court to reverse his dismissal. The firm has accelerated the schedule for the change-in-command to Duane Burnham. Named president in early December, Burnham was elevated to chairman on March 9. He was supposed to take over that job from Schoellhorn in August. Schoellhorn is also being removed from the board. Acrimony has surrounded Schoellhorn's executive reign during the last decade. His departure amidst a corporate feud may be fitting given the executive in-fighting during his tenure, but it is not a graceful ending to a period of great growth for the company during his 16-year career.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS017074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel